Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients
- 40 Downloads
- 13 Citations
Summary
Cytogenetic studies in patients with multiple myeloma (MM) and plasma cell leukemia (PCL) have in general been largely unsuccessful. The investigation of mitoses of nonmalignant hematopoietic precursor cells, rather than mitoses of malignant plasma cells might account for the low percentage of pathological genetic findings. We investigated bone marrow (BM) cells of 51 patients both cytogenetically and cytologically. In patients with a normal karyotype (n=39) nearly all mitoses examined cytologically (107/117) derived from granulopoietic or erythropoietic cell lineages. In contrast, 20/27 metaphases in patients with a pathological karyotype (n=12) were found to be plasma cell mitoses. These findings may explain the low rate of chromosomal rearrangements in MM and may suggest that the real abnormality rate is considerably higher.
Key words
Multiple myeloma Plasma cell leukemia Cytogenetics CytologyPreview
Unable to display preview. Download preview PDF.
References
- 1.Barlogie B, Alexanian R, Dixon D, Smith L, Smallwood L, Delasalle K (1985) Prognostic implications of tumor cell DNA And RNA content in multiple myeloma. Blood 6: 338–341Google Scholar
- 2.Bast RC, De Fabritiis P, Lipton J et al. (1985) Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res 45: 499PubMedGoogle Scholar
- 3.Berger R, Bernheim A, Daniel MT, Valensi F, Flandrin G (1983) Cytological types of mitoses and chromosome abnormalities in acute leukemia. Leukemia Res 7: 221–236Google Scholar
- 4.Berghe H van den (1991) Chromosomes in plasma-cell malignancies. Eur J Haematol 43 [Suppl 51]: 47–51Google Scholar
- 5.Clark RE, Geddes AD, Whittaker JA, Jacobs A (1989) Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. Eur J Clin Oncol 25: 1789–1793Google Scholar
- 6.Dewald GW, Kyle RA, Hicks GA, Greipp PR (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66: 380–390PubMedGoogle Scholar
- 7.Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988) Plasma cell karyotype in multiple myeloma. Blood 71: 453–456PubMedGoogle Scholar
- 8.Kawano M, Hirano T, Matsuda T et al. (1988) Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332: 83–85PubMedGoogle Scholar
- 9.Klein B, Zhang XG, Jourdan M et al. (1989) Paracrine rther than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood 73: 517–526PubMedGoogle Scholar
- 10.Le Bien TW, Stepan DE, Bartholomew RM et al. (1985) Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. Blood 65: 945PubMedGoogle Scholar
- 11.Maitland JA, Millar BC, Bell JBG et al. (1990) Evidence that multiple myeloma may be regulated by hemeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response. Br J Cancer 61: 429–433PubMedGoogle Scholar
- 12.Ranni NS, Slavutsky I, Wechsler A, Brieux de Salum S (1987) Chromosome findigs in multiple myeloma. Cancer Genet Cytogenet 25: 309–316PubMedGoogle Scholar
- 13.Seabright M (1971) A rapid banding technique for human Chromosomes. Lancet 2: 971–972Google Scholar
- 14.Shimazaki C, Wisniewski D, Scheinberg DA et al. (1988) Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads. Blood 72: 1248–1254PubMedGoogle Scholar
- 15.Weh HJ, Fiedler W, Hossfeld DK (1990) Cytogenetics in multiple myeloma: Are we studying the “right” cells? Eur J Haematol 45: 236PubMedGoogle Scholar